Search research articles
Contact Us
Filters
Showing results (811-820 of 993) with videos related to
Page
of 100
Sort By:
World Journal of Urology
|
April 11, 2026
Years of life lost in squamous cell carcinoma of the penis
Federico Polverino, Calogero Catanzaro, Michele Nicolazzini, et al.
The Lancet. Oncology
|
February 8, 2022
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Matthew R Smith, Howard I Scher, Shahneen Sandhu, et al.
The Lancet. Oncology
|
September 22, 2012
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi, Howard I Scher, Arturo Molina, et al.
The Prostate
|
October 25, 2024
Life Expectancy in High-Grade Incidental Prostate Cancer Patients Versus Population-Based Controls According to Treatment Type
Francesco Di Bello, Letizia Maria Ippolita Jannello, Andrea Baudo, et al.
European Urology Open Science
|
October 3, 2022
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
Benedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Journal of Surgical Oncology
|
August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma
Mattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment
Reha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Prostate Cancer and Prostatic Diseases
|
October 23, 2023
Characteristics of incidental prostate cancer in the United States
Lukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
The New England Journal of Medicine
|
February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
World Journal of Urology
|
June 30, 2025
The effect of race/ethnicity on systemic chemotherapy in urothelial carcinoma patients exposed to radiotherapy
Mario de Angelis, Carolin Siech, Francesco Di Bello, et al.
Page
of 100
Search research articles
Search
Showing results (811-820 of 993) with videos related to
Sort By:
Page
of 100
World Journal of Urology
|
April 11, 2026
Years of life lost in squamous cell carcinoma of the penis
Federico Polverino, Calogero Catanzaro, Michele Nicolazzini, et al.
The Lancet. Oncology
|
February 8, 2022
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Matthew R Smith, Howard I Scher, Shahneen Sandhu, et al.
The Lancet. Oncology
|
September 22, 2012
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi, Howard I Scher, Arturo Molina, et al.
The Prostate
|
October 25, 2024
Life Expectancy in High-Grade Incidental Prostate Cancer Patients Versus Population-Based Controls According to Treatment Type
Francesco Di Bello, Letizia Maria Ippolita Jannello, Andrea Baudo, et al.
European Urology Open Science
|
October 3, 2022
Effect of Inferior Vena Cava Tumor Thrombus on Overall Survival in Metastatic Renal Cell Carcinoma Patients Treated with Cytoreductive Nephrectomy
Benedikt Hoeh, Rocco Simone Flammia, Lukas Hohenhorst, et al.
Journal of Surgical Oncology
|
August 26, 2024
Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma
Mattia Luca Piccinelli, Cristina Cano Garcia, Andrea Panunzio, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 5, 2024
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment
Reha-Baris Incesu, Simone Morra, Lukas Scheipner, et al.
Prostate Cancer and Prostatic Diseases
|
October 23, 2023
Characteristics of incidental prostate cancer in the United States
Lukas Scheipner, Reha-Baris Incesu, Simone Morra, et al.
The New England Journal of Medicine
|
February 9, 2018
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer
Matthew R Smith, Fred Saad, Simon Chowdhury, et al.
World Journal of Urology
|
June 30, 2025
The effect of race/ethnicity on systemic chemotherapy in urothelial carcinoma patients exposed to radiotherapy
Mario de Angelis, Carolin Siech, Francesco Di Bello, et al.
Page
of 100